Emergency Room Treatment for Extensive DVT

Immediate Anticoagulation Strategy

The American College of Chest Physicians recommends initiating anticoagulation immediately with either a direct oral anticoagulant (DOAC) such as apixaban or rivaroxaban, or with low-molecular-weight heparin (LMWH) or fondaparinux, and treating the patient at home if circumstances are adequate 1, 2
Direct Oral Anticoagulants (DOACs) are strongly preferred over vitamin K antagonists (VKAs) for acute DVT treatment, based on moderate-certainty evidence 1, 2
The American Society of Hematology suggests anticoagulation therapy alone over thrombolytic therapy for most patients with proximal DVT, with a conditional recommendation and low-certainty evidence 2

If DOACs are contraindicated or unavailable, the American College of Chest Physicians suggests using LMWH or fondaparinux over unfractionated heparin, with a weak recommendation and low-certainty evidence 1, 4

The American College of Chest Physicians recommends treating patients at home rather than admitting to the hospital, provided home circumstances are adequate, with a strong recommendation and moderate-certainty evidence 1, 5

Anticoagulation alone is preferred over catheter-directed thrombolysis (CDT) in most patients, but thrombolysis may be reasonable to consider for limb-threatening DVT or selected younger patients at low risk for bleeding 2, 4

The American College of Chest Physicians recommends a minimum of 3 months of anticoagulation for all patients with acute VTE without contraindications, with a strong recommendation and moderate-certainty evidence 1, 5
Extended anticoagulation beyond 3 months depends on provocation status, with a strong recommendation for unprovoked DVT or persistent risk factor, and a recommendation against extended anticoagulation for major transient risk factor 1

The American Society of Hematology suggests avoiding DOACs in patients with severe renal insufficiency, moderate to severe liver disease, or antiphospholipid syndrome, and using caution in patients with bleeding risks 2
If anticoagulation is absolutely contraindicated, the American College of Chest Physicians recommends placing an inferior vena cava (IVC) filter, with a strong recommendation 1, 5

The American College of Chest Physicians strongly recommends against routinely placing IVC filters in addition to anticoagulation, with a strong recommendation and moderate-certainty evidence 1, 5
The American College of Chest Physicians recommends not delaying anticoagulation while awaiting confirmatory imaging if clinical suspicion is high, with a Grade 2C recommendation 7